Orchestra BioMed Inc. (OBIO)

AI Score

Unlock

2.97

0.37 (14.23%)

At close: Apr 11, 2025, 3:59 PM

3.00

1.01%

After-hours: Apr 11, 2025, 05:23 PM EDT

Orchestra BioMed Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	22.26M	25.61M	23.71M	23.32M	30.56M	19.08M	16.41M	18.7M	175.16K	735.22K	106.97M	1.42M	9.94M	1.78M	1.91M	1.95M
Short-Term Investments	44.55M	41.32M	41.47M	51.71M	57.04M	89.77M	101.36M	108.54M	64M	251K	579K	738K	958K	n/a	n/a	n/a
Long-Term Investments	2.5M	2.5M	2.5M	2.5M	2.5M	2.5M	2.5M	2.5M	67.78M	67.78M	2.5M	160.04M	398K	160.02M	160.01M	160.01M
Other Long-Term Assets	1.02M	1.3M	841K	894K	769K	604K	517K	421K	-3.68M	-3.84M	2.19M	-3.6M	690K	n/a	n/a	n/a
Receivables	92K	115K	80K	67K	99K	86K	171K	76K	96K	96K	80K	79K	121K	n/a	n/a	n/a
Inventory	173K	234K	70K	115K	146K	137K	178K	232K	276K	330K	133K	32K	68K	n/a	n/a	n/a
Other Current Assets	2.09M	1.28M	1.15M	1.21M	1.27M	1.12M	1.47M	2.34M	n/a	-426K	n/a	-111K	n/a	n/a	n/a	n/a
Total Current Assets	69.17M	68.55M	66.48M	76.43M	89.11M	110.19M	119.59M	129.88M	299.08K	872.55K	108.6M	1.49M	11.32M	1.86M	2.02M	2.09M
Property-Plant & Equipment	3.49M	2.97M	2.57M	2.81M	2.83M	3.07M	3.28M	3.48M	3.68M	3.84M	3.82M	3.6M	1.12M	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	7M	6.77M	5.9M	6.2M	6.1M	6.17M	6.29M	6.4M	67.78M	67.78M	8.51M	160.04M	2.21M	160.02M	160.01M	160.01M
Total Assets	76.17M	75.32M	72.38M	82.63M	95.21M	116.36M	125.88M	136.28M	68.08M	68.65M	117.11M	161.53M	13.53M	161.88M	162.03M	162.1M
Account Payables	5.13M	4.72M	6.27M	3.35M	2.9M	3.15M	3.01M	2.77M	3.97M	7.69M	3.84M	2.16M	2.03M	n/a	n/a	n/a
Deferred Revenue	4.44M	4.07M	3.66M	3.07M	2.51M	3.68M	4.29M	5.33M	6.44M	n/a	5M	-3.16M	5.54M	n/a	n/a	n/a
Short-Term Debt	550K	n/a	350K	n/a	649K	9.6M	n/a	n/a	n/a	n/a	n/a	1M	2M	n/a	n/a	n/a
Other Current Liabilities	2.61M	7.03M	2.1M	2.53M	2.01M	1.73M	1.87M	2.35M	-8.3M	-11.68M	12.18M	-6.06M	6.32M	136.83K	194.89K	174.47K
Total Current Liabilities	16.21M	16.22M	14.5M	10.42M	11.21M	21.47M	11.86M	12.06M	1.74M	1.44M	19.7M	306.54K	12.24M	136.83K	194.89K	174.47K
Long-Term Debt	1.69M	n/a	n/a	n/a	n/a	n/a	9.56M	9.53M	9.49M	9.45M	9.42M	3.73M	3.67M	n/a	n/a	n/a
Other Long-Term Liabilities	25.32M	n/a	n/a	n/a	n/a	266K	213K	249K	-5.57M	-5.72M	165.94M	-244K	-34.06M	5.6M	5.6M	5.6M
Total Long-Term Liabilities	27.01M	12.88M	13.75M	15.02M	15.96M	15.23M	24.58M	24.47M	5.6M	5.6M	193.85M	5.6M	72.52M	5.6M	5.6M	5.6M
Total Liabilities	43.22M	29.1M	28.26M	25.44M	27.17M	36.7M	36.44M	36.53M	7.34M	7.04M	213.55M	5.91M	84.76M	5.74M	5.79M	5.77M
Total Debt	2.24M	1.84M	1.45M	1.62M	1.69M	11.46M	11.6M	11.74M	11.87M	11.32M	12.13M	6.84M	5.67M	n/a	n/a	n/a
Common Stock	4K	4K	4K	4K	4K	4K	4K	3K	67.68M	67.68M	160.14M	160M	160M	160M	151.24M	151.33M
Retained Earnings	-309.88M	-293.72M	-278.3M	-262.32M	-248.85M	-236.04M	-222.72M	-210.67M	-6.95M	-6.07M	-179.7M	-4.38M	-166.13M	-3.85M	-373.87K	-281.54K
Comprehensive Income	52K	98K	-23K	-8K	-10K	-77K	-96K	-35K	-8K	0.00	-326.09M	-236.71M	-211.45M	n/a	n/a	n/a
Shareholders Equity	32.96M	46.22M	44.13M	57.19M	68.04M	79.66M	89.44M	99.75M	60.73M	61.61M	-96.44M	155.62M	-71.23M	156.15M	156.24M	156.33M
Total Investments	47.05M	43.82M	43.96M	54.21M	59.53M	92.27M	103.86M	111.03M	67.78M	67.78M	3.07M	160.04M	1.36M	160.02M	160.01M	160.01M